從(cong)78年(nian)起(qi)主(zhu)編(bian)(bian)(bian)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)唯一腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)專科(ke)(ke)雜志《癌癥—化(hua)(hua)(hua)療(liao)專輯》,迄今已出(chu)版40輯。97年(nian)起(qi)編(bian)(bian)(bian)印(yin)出(chu)版《腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)通訊》,對促進(jin)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)本專科(ke)(ke)學(xue)(xue)術(shu)水平(ping)起(qi)到(dao)積(ji)(ji)極推動作(zuo)用,先后招(zhao)收碩士、博士研(yan)究生(sheng)26名,培(pei)養(yang)本專業學(xue)(xue)術(shu)骨(gu)干。1979年(nian)起(qi)主(zhu)持本單位腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)專科(ke)(ke)進(jin)修班(ban),先后培(pei)養(yang)化(hua)(hua)(hua)療(liao)進(jin)修生(sheng)約200名,據統計迄今已有50多人(ren)擔任(ren)各地(di)化(hua)(hua)(hua)療(liao)科(ke)(ke)主(zhu)任(ren),82人(ren)取得副高(gao)以(yi)上職(zhi)稱。另外積(ji)(ji)極舉辦參(can)與國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)多項專科(ke)(ke)培(pei)訓班(ban)、講座及(ji)(ji)學(xue)(xue)術(shu)座談會授課(ke),為(wei)(wei)建設我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)專科(ke)(ke)學(xue)(xue)術(shu)隊伍作(zuo)出(chu)貢獻。1985年(nian)、1995年(nian)兩次(ci)編(bian)(bian)(bian)寫《腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)學(xue)(xue)治療(liao)》講義為(wei)(wei)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)各地(di)同行歡迎,1995年(nian)為(wei)(wei)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)主(zhu)要(yao)(yao)大(da)型參(can)考書《腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)學(xue)(xue)》(張天澤、徐光(guang)煒主(zhu)編(bian)(bian)(bian))撰寫《腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)學(xue)(xue)治療(liao)》篇,1998年(nian)為(wei)(wei)陳敏章主(zhu)編(bian)(bian)(bian)《中(zhong)華(hua)內(nei)(nei)科(ke)(ke)學(xue)(xue)》撰寫《臨床(chuang)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)學(xue)(xue)基礎》,均成為(wei)(wei)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)或(huo)(huo)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)內(nei)(nei)科(ke)(ke)學(xue)(xue)的主(zhu)要(yao)(yao)教材。努力培(pei)養(yang)嚴謹(jin)的學(xue)(xue)風及(ji)(ji)認真負責的醫療(liao)作(zuo)風,將本單位建設成為(wei)(wei)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)主(zhu)要(yao)(yao)的腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)學(xue)(xue)術(shu)基地(di)。1986年(nian)起(qi)先后被衛(wei)生(sheng)部、SDA確定(ding)為(wei)(wei)部屬(shu)抗腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)藥(yao)物(wu)臨床(chuang)研(yan)究基地(di),2001年(nian)通過論證被國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)科(ke)(ke)委確定(ding)成為(wei)(wei)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)首家(jia)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)級抗腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)藥(yao)物(wu)化(hua)(hua)(hua)療(liao)臨床(chuang)研(yan)究中(zhong)心,將為(wei)(wei)我(wo)(wo)國(guo)(guo)(guo)(guo)(guo)(guo)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)(liu)(liu)化(hua)(hua)(hua)療(liao)學(xue)(xue)科(ke)(ke)的發展帶頭及(ji)(ji)示(shi)范作(zuo)用。積(ji)(ji)極開展國(guo)(guo)(guo)(guo)(guo)(guo)際(ji)學(xue)(xue)術(shu)交流,為(wei)(wei)本學(xue)(xue)科(ke)(ke)學(xue)(xue)術(shu)水平(ping)的提高(gao)創造條(tiao)件,先后赴美、英、法、德、日、意等各國(guo)(guo)(guo)(guo)(guo)(guo)參(can)與講學(xue)(xue)或(huo)(huo)學(xue)(xue)術(shu)討論,在國(guo)(guo)(guo)(guo)(guo)(guo)際(ji)上已建立一定(ding)的知(zhi)名度。
管(guan)忠震教(jiao)(jiao)授(shou)(shou)(shou)為(wei)(wei)(wei)我(wo)國(guo)(guo)(guo)抗(kang)腫(zhong)(zhong)瘤藥物(wu)(wu)的(de)(de)(de)(de)研(yan)制發(fa)(fa)展(zhan)作(zuo)(zuo)(zuo)出(chu)貢獻。70年(nian)(nian)(nian)代國(guo)(guo)(guo)內(nei)(nei)多省(sheng)(sheng)協(xie)作(zuo)(zuo)(zuo)對(dui)三(san)(san)尖杉類植物(wu)(wu)生(sheng)(sheng)物(wu)(wu)堿(jian)的(de)(de)(de)(de)抗(kang)腫(zhong)(zhong)瘤作(zuo)(zuo)(zuo)用進(jin)行(xing)研(yan)究(jiu)(jiu)(jiu),管(guan)教(jiao)(jiao)授(shou)(shou)(shou)被(bei)指(zhi)定負責臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu)匯總,首先(xian)提出(chu)“粗榧堿(jian)”為(wei)(wei)(wei)基本無效成(cheng)分,而酯(zhi)(zhi)類生(sheng)(sheng)物(wu)(wu)堿(jian)(三(san)(san)尖杉酯(zhi)(zhi)堿(jian)及(ji)(ji)高三(san)(san)尖杉酯(zhi)(zhi)堿(jian))為(wei)(wei)(wei)主(zhu)要(yao)有效成(cheng)分。在(zai)(zai)(zai)國(guo)(guo)(guo)內(nei)(nei)首先(xian)報告(gao)阿霉素的(de)(de)(de)(de)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)應(ying)用經(jing)驗(yan)(1980,北京國(guo)(guo)(guo)際腫(zhong)(zhong)瘤學術會(hui)(hui)(hui)(hui)議)。在(zai)(zai)(zai)國(guo)(guo)(guo)內(nei)(nei)首先(xian)進(jin)行(xing)順(shun)鉑的(de)(de)(de)(de)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu)及(ji)(ji)長(chang)春花堿(jian)的(de)(de)(de)(de)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu),此后(hou),主(zhu)持了多種重(zhong)要(yao)抗(kang)癌(ai)藥物(wu)(wu)在(zai)(zai)(zai)我(wo)國(guo)(guo)(guo)的(de)(de)(de)(de)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu),包(bao)括卡(ka)鉑、異(yi)環磷酰胺、諾維(wei)本、紫杉醇(chun)、健(jian)擇、依立替(ti)康(kang)、拓撲替(ti)康(kang)、希羅達、來曲唑、美羅華、吉非替(ti)尼(ni)等,以及(ji)(ji)我(wo)國(guo)(guo)(guo)首創的(de)(de)(de)(de)基因重(zhong)組(zu)(zu)溶瘤腺病(bing)毒、雙(shuang)環鉑等新抗(kang)癌(ai)藥物(wu)(wu)的(de)(de)(de)(de)研(yan)究(jiu)(jiu)(jiu)。1986年(nian)(nian)(nian)起(qi)(qi)擔任(ren)(ren)衛(wei)生(sheng)(sheng)部(bu)(bu)及(ji)(ji)SDA抗(kang)癌(ai)藥物(wu)(wu)審評(ping)委(wei)(wei)員(yuan)會(hui)(hui)(hui)(hui)委(wei)(wei)員(yuan),1992年(nian)(nian)(nian)起(qi)(qi)任(ren)(ren)主(zhu)任(ren)(ren)委(wei)(wei)員(yuan),協(xie)助國(guo)(guo)(guo)家(jia)(jia)衛(wei)生(sheng)(sheng)行(xing)政(zheng)部(bu)(bu)門保障(zhang)我(wo)國(guo)(guo)(guo)抗(kang)癌(ai)藥物(wu)(wu)健(jian)康(kang)發(fa)(fa)展(zhan)。1986年(nian)(nian)(nian)及(ji)(ji)1998年(nian)(nian)(nian)先(xian)后(hou)受(shou)衛(wei)生(sheng)(sheng)部(bu)(bu)及(ji)(ji)SDA委(wei)(wei)托,負責起(qi)(qi)草(cao)我(wo)國(guo)(guo)(guo)《抗(kang)腫(zhong)(zhong)瘤藥物(wu)(wu)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu)指(zhi)導(dao)原則》。從60年(nian)(nian)(nian)代開始(shi),管(guan)教(jiao)(jiao)授(shou)(shou)(shou)致(zhi)力于改善淋巴瘤臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)療效方面的(de)(de)(de)(de)臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)研(yan)究(jiu)(jiu)(jiu)。對(dui)何(he)杰金氏病(bing),管(guan)教(jiao)(jiao)授(shou)(shou)(shou)從我(wo)國(guo)(guo)(guo)國(guo)(guo)(guo)情出(chu)發(fa)(fa),提出(chu)簡化分期診斷操作(zuo)(zuo)(zuo)、以全身化療為(wei)(wei)(wei)主(zhu)、侵犯野(ye)補(bu)充放療為(wei)(wei)(wei)輔的(de)(de)(de)(de)治(zhi)療策略并付(fu)諸臨(lin)(lin)(lin)床(chuang)(chuang)(chuang)實踐,取得(de)成(cheng)功(gong)。管(guan)教(jiao)(jiao)授(shou)(shou)(shou)的(de)(de)(de)(de)論文在(zai)(zai)(zai)1990年(nian)(nian)(nian)第15屆(jie)UICC世界(jie)腫(zhong)(zhong)瘤大(da)(da)會(hui)(hui)(hui)(hui)上被(bei)選為(wei)(wei)(wei)亞洲的(de)(de)(de)(de)代表經(jing)驗(yan)在(zai)(zai)(zai)大(da)(da)會(hui)(hui)(hui)(hui)報告(gao)獲得(de)好(hao)評(ping),其設想已(yi)為(wei)(wei)(wei)各國(guo)(guo)(guo)的(de)(de)(de)(de)經(jing)驗(yan)所(suo)證(zheng)實。對(dui)非何(he)杰金氏淋巴瘤,早在(zai)(zai)(zai)1982年(nian)(nian)(nian)管(guan)教(jiao)(jiao)授(shou)(shou)(shou)即發(fa)(fa)表了456例(li)治(zhi)療經(jing)驗(yan),并不斷努(nu)力改進(jin),據1999年(nian)(nian)(nian)統(tong)計,該科(ke)90年(nian)(nian)(nian)代NHL治(zhi)療水平(ping)(ping),長(chang)期存活率已(yi)達45%,達到(dao)國(guo)(guo)(guo)際先(xian)進(jin)水平(ping)(ping)。管(guan)忠震教(jiao)(jiao)授(shou)(shou)(shou)治(zhi)學嚴謹(jin)、學風正派、教(jiao)(jiao)書育人。1979年(nian)(nian)(nian)獲得(de)“廣東省(sheng)(sheng)優秀教(jiao)(jiao)師”稱號(hao),連續擔任(ren)(ren)第七屆(jie)、八屆(jie)、九屆(jie)全國(guo)(guo)(guo)政(zheng)協(xie)委(wei)(wei)員(yuan),并擔任(ren)(ren)廣東省(sheng)(sheng)及(ji)(ji)中(zhong)央保健(jian)專家(jia)(jia)組(zu)(zu)成(cheng)員(yuan),曾任(ren)(ren)衛(wei)生(sheng)(sheng)部(bu)(bu)腫(zhong)(zhong)瘤工作(zuo)(zuo)(zuo)領導(dao)小組(zu)(zu)成(cheng)員(yuan)、衛(wei)生(sheng)(sheng)部(bu)(bu)腫(zhong)(zhong)瘤專家(jia)(jia)咨詢組(zu)(zu)成(cheng)員(yuan),現任(ren)(ren)中(zhong)國(guo)(guo)(guo)抗(kang)癌(ai)協(xie)會(hui)(hui)(hui)(hui)常務會(hui)(hui)(hui)(hui)理(li)事(shi),化療專業(ye)委(wei)(wei)員(yuan)會(hui)(hui)(hui)(hui)主(zhu)任(ren)(ren)委(wei)(wei)員(yuan),廣東省(sheng)(sheng)抗(kang)癌(ai)協(xie)會(hui)(hui)(hui)(hui)理(li)事(shi)長(chang),1994年(nian)(nian)(nian)被(bei)香港中(zhong)文大(da)(da)學癌(ai)癥研(yan)究(jiu)(jiu)(jiu)所(suo)聘(pin)任(ren)(ren)為(wei)(wei)(wei)科(ke)學顧問(wen)。
1995年被美國人物傳記中心(ABI)授予“腫(zhong)瘤內科學(xue)突出(chu)貢(gong)獻(xian)獎”。